InflaRx (IFRX) Shares Outstanding (Diluted) (2017 - 2026)
InflaRx (IFRX) recorded Shares Outstanding (Diluted) of 67.29 million in Q2 2026, up 14.2% from 58.92 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
InflaRx (IFRX) Shares Outstanding (Diluted) (2017 - 2026) Analysis & Trends
Starting with Q4 2017, InflaRx's Shares Outstanding (Diluted) history includes 35 quarters.
- Annual Shares Outstanding (Diluted) has increased for eight straight years, with a five-year compound annual growth rate of 20.0% (FY2020 to FY2025).
- Across earlier years, Shares Outstanding (Diluted) came in at 58.92 million in FY2024 (+7.2%), 54.94 million in FY2023 (+24.3%), 44.21 million in FY2022 (+6.2%) and 41.63 million in FY2021 (+53.8%).
- On a year-over-year basis, Shares Outstanding (Diluted) has increased for 31 consecutive quarters, with growth averaging 12.0% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 4.1% in Q3 2021 to 53.8% in Q3 2022.
- Per Business Quant, the preceding three quarters came in at 67.29 million (Q1 2026), 67.29 million (Q4 2025) and 58.92 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 5.70 Bn |
| 10 | InflaRx | 103.29 Mn | -230.33 Mn | 2.74 Mn | 67.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 67.29 Mn |
| Mar 31, 2026 | 67.29 Mn |
| Dec 31, 2025 | 67.29 Mn |
| Sep 30, 2025 | 58.92 Mn |
| Jun 30, 2025 | 58.92 Mn |
| Mar 31, 2025 | 58.92 Mn |
| Dec 31, 2024 | 58.92 Mn |
| Sep 30, 2024 | 54.94 Mn |
| Jun 30, 2024 | 54.94 Mn |
| Mar 31, 2024 | 54.94 Mn |
| Dec 31, 2023 | 54.94 Mn |
| Sep 30, 2023 | 44.21 Mn |
| Jun 30, 2023 | 44.21 Mn |
| Mar 31, 2023 | 44.21 Mn |
| Dec 31, 2022 | 44.21 Mn |
| Sep 30, 2022 | 41.63 Mn |
| Jun 30, 2022 | 41.63 Mn |
| Mar 31, 2022 | 41.63 Mn |
| Dec 31, 2021 | 41.63 Mn |
| Sep 30, 2021 | 27.06 Mn |
API Access
InflaRx Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=IFRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "IFRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=IFRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();